Abstract
Background
Hypertension is a common problem in stage 5 chronic kidney disease (CKD 5) and following kidney transplantation (KT). There is limited data on the outcome of children with CKD 5 who undergo bilateral native nephrectomies (BNN) for the management of hypertension.
Method
Retrospective review of 134 children who underwent KT at a single centre over a 10-year period and had a minimum follow up period of 1 year. Children who had undergone BNN for hypertension prior to, and after, KT were identified and their outcome with regard to blood pressure (BP), anti-hypertensive medications and graft function was compared with that of the rest of the cohort.
Results
Eleven children (8.2%) underwent BNN, including 2 performed after KT, due to poorly controlled BP despite a median of 3 anti-hypertensive medications. The median age at BNN was 7 years (range 0.5–17 years). All 9 children who underwent BNN prior to KT discontinued anti-hypertensive medication after a median of 6 months and remained normotensive post KT. After a median follow up of 5 years following KT, there was a trend towards lower prevalence of hypertension in children who underwent BNN compared with that of the rest of the cohort (9.1% vs 25%, p 0.23). None of the children who underwent BNN had any evidence of proteinuria, and the median eGFR was 74 ml/min/1.73 m 2 after KT.
Conclusion
BNN for severe hypertension in CKD 5 is associated with resolution of hypertension prior to KT. It is also associated with a trend towards lower prevalence of hypertension and good graft function following KT.
Similar content being viewed by others
References
Seeman T (2009) Hypertension after renal transplantation. Pediatr Nephrol 24:959–972
Sinha MD, Gilg JA, Kerecuk L, Reid CJ, British Association for Paediatric Nephrology (2012) Progression to hypertension in non-hypertensive children following renal transplantation. Nephrol Dial Transplant 27:2990–2996
Stabouli S, Printza N, Dotis J, Gkogka C, Kollios K, Kotsis V, Papachristou F (2016) Long-term changes in blood pressure after pediatric kidney transplantation. Am J Hypertens 29:860–865
Mitsnefes MM (2004) Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 8:394–399
Brubaker AL, Stoltz DJ, Chaudhuri A, Maestretti L, Grimm PC, Concepcion W, Gallo AE (2018) Superior hypertension management in pediatric kidney transplant patients after native nephrectomy. Transplant 102:1172–1178
Cavallini M, Di Zazzo G, Giordano U, Pongiglione G, Strologo LD, Capozza N, Emma F, Matteucci MC (2010) Long-term cardiovascular effects of pre-transplant native kidney nephrectomy in children. Pediatr Nephrol 25:2523–2529
National High Blood Pressure Education Program (2005) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents (No. 5). US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, National Height Blood Pressure Education Program. Pediatrics 114:555–576
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wuhl E, Zanchetti A (2016) European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887–1920
Grenda R, Watson A, Trompeter R, Tönshoff B, Jaray J, Fitzpatrick M, Murer L, Vondrak K, Maxwell H, Van Damme-Lombaerts R, Loirat C (2010) A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant 10:828–836
Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C (1982) Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 57:611–615
Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B (2002) Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 17:141–149
Webb NJ, Douglas SE, Rajai A, Roberts SA, Grenda R, Marks SD, Watson AR, Fitzpatrick M, Vondrak K, Maxwell H, Jaray J (2015) Corticosteroid-free kidney transplantation improves growth: 2-year follow-up of the TWIST randomized controlled trial. Transplant 99:1178–1185
Mitsnefes MM (2005) Cardiovascular morbidity and mortality in children with chronic kidney disease in North America: lessons from the USRDS and NAPRTCS databases. Perit Dial Int 25(Suppl 3):S120–S122
Sorof JM, Sullivan EK, Tejani AMIR, Portman RJ (1999) Antihypertensive medication and renal allograft failure: a North American pediatric renal transplant cooperative study report. J Am Soc Nephrol 10:1324–1330
Mitsnefes MM, Khoury PR, McEnery PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98–103
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pickles, C., Kaur, A., Wallace, D. et al. Bilateral native nephrectomies for severe hypertension in children with stage 5 chronic kidney disease leads to improved BP control following transplantation. Pediatr Nephrol 35, 2373–2376 (2020). https://doi.org/10.1007/s00467-020-04738-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-020-04738-6